Submission Details


leukoencephalopathy with vanishing white matter
Mode Of Inheritance:
Autosomal recessive
Evaluated Date:
The EIF2B2 gene is located on chromosome 14 at 14q24.3 and encodes eukaryotic translation initiation factor 2B subunit beta. EIF2B2 forms a protein complex with four other EIF2B subunits and plays an important role in the initiation of mRNA translation by activating protein synthesis initiation factor 2 through its guanine nucleotide exchange factor activity. EIF2B2 was first reported in relation to leukoencephalopathy with vanishing white matter in 2001 (11704758: Leegwater et al. 2001). Evidence supporting this gene-disease relationship includes case-level data and experimental data. At least 12 variants, including missense and loss of function variants have been reported in at least eight probands from four publications (11704758: Leegwater et al. 2001; 14566705: van der Knapp et al. 2003; 15054402: Fogli et al. 2004; 21484434: Matsukawa et al. 2011). More evidence is available in the literature, but the maximum score for genetic evidence has been reached. Clinical evidence indicates that loss of function is the mechanism of disease. This gene-disease association is supported by the biochemical function of EIF2B2 and other genes in the EIF2B complex are associated with the disease (20301435: van der Knaap et al. 2019). Co-immunoprecipitation experiments demonstrate an interaction between EIF2B2 and all four of the other EIF2B subunits (14993275: Richardson et al. 2004). In vitro functional analyses of patient-identified missense variants suggest loss of function, including disruption of interactions with other subunits and impaired translation (14993275: Richardson et al. 2004). In summary, the EIF2B2 gene is definitively associated with leukoencephalopathy with vanishing white matter.
PubMed IDs:
11704758 15136673 20301435 14993275 14566705 15054402 21484434 30720246 20826436
Assertion Criteria:
Submitter Submitted Date:

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact